Better Therapeutics, Inc.Better Therapeutics, Inc.Better Therapeutics, Inc.

Better Therapeutics, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪440.26 K‬USD
−1.1572USD
‪−39.76 M‬USD
‪30.89 M‬
Beta (1Y)
3.22

About Better Therapeutics, Inc.

CEO
Craig R. Jalbert
Headquarters
San Francisco
Employees (FY)
54
Founded
2015
FIGI
BBG00YZ55XT6
Better Therapeutics, Inc. operates as a digital therapeutics company, which engages in developing a novel form of cognitive behavioral therapy to address the root causes of cardio metabolic diseases. It offers software-based solutions for type 2 diabetes, heart disease and other conditions. The company was founded by Kevin J. Appelbaum and David P. Perry in April 2015 and is headquartered in San Francisco, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of BTTX is 0.0081 USD — it has decreased by 19.00% in the past 24 hours. Watch Better Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Better Therapeutics, Inc. stocks are traded under the ticker BTTX.
BTTX stock has fallen by 37.69% compared to the previous week, the month change is a 35.00% rise, over the last year Better Therapeutics, Inc. has showed a 98.88% decrease.
BTTX reached its all-time high on Nov 1, 2021 with the price of 29.4000 USD, and its all-time low was 0.0050 USD and was reached on Apr 5, 2024. View more price dynamics on BTTX chart.
See other stocks reaching their highest and lowest prices.
BTTX stock is 41.67% volatile and has beta coefficient of 3.22. Track Better Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Better Therapeutics, Inc. there?
Today Better Therapeutics, Inc. has the market capitalization of ‪440.26 K‬, it has decreased by 16.67% over the last week.
Yes, you can track Better Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Better Therapeutics, Inc. is going to release the next earnings report on May 27, 2024. Keep track of upcoming events with our Earnings Calendar.
BTTX net income for the last quarter is ‪−5.86 M‬ USD, while the quarter before that showed ‪−7.59 M‬ USD of net income which accounts for 22.76% change. Track more Better Therapeutics, Inc. financial stats to get the full picture.
No, BTTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 26, 2024, the company has 54.00 employees. See our rating of the largest employees — is Better Therapeutics, Inc. on this list?
Like other stocks, BTTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Better Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Better Therapeutics, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Better Therapeutics, Inc. stock shows the sell signal. See more of Better Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.